How Wearable Medical Devices are transforming Healthcare Industry

Wearable medical devices are autonomous, non-invasive devices that perform a specific medical function such as monitoring or support over a prolonged period of time. These devices are used in the treatment of various chronic illnesses such as asthma, diabetes, and heart disease. The main function of these devices is to collect information about the patient’s health condition. The growth of the global wearable medical device market can be attributed to technological advancements, an increasing number of smartphone-based healthcare apps compatible with wearable devices, and rising awareness about physical fitness.  

Global Wearable Medical Device Market 2023

As the wearable health technology market continues to grow it can be hard to distinguish the trendy consumer devices from those with useful medical applications. From the debate over smart watches to the latest wearable MRI scanner. Many of them are pointing the way to the future of patient care.

In the ever growing wearable health technology market, Fitbit is arguably the most well-known brand. Extremely popular with consumers, fitness tracking Fitbit watches are not a favorite among medical professionals due to claims that the patient data collected is not accurate enough for medical assertions to be made. However, Fitbit remains determined to break into the healthcare market and partnered with Google earlier this year to improve the ability of its devices to share data with medical professionals. The fitness wearable company has adopted Google Cloud for Healthcare application programming interfaces (APIs) in a bid to make data sharing more secure.

The more medically trusted smart watches include the FDA-approved Empatica smartwatch, called Embrace, which is designed to monitor seizures. The AI-powered device uses advanced machine learning to check for grand mal or generalised tonic-clonic seizures and can send instant alerts to caregivers.

These types of wearable scanners are so new that further research and development is needed before their future and relevance in the healthcare industry can be fully determined.

The global wearable medical device market is expected to reach a market value of USD 27,255.6 million by 2023 from USD 7,859.4 million in 2017 at a CAGR of 23.0% during the forecast period of 2018 to 2023.

In 2017, the Americas held the largest share of the market at 33.3%, followed by Europe and Asia-Pacific with shares of 27.2% and 24.4 %, respectively.

Market Segmentation

The global wearable medical device market has been segmented based on type, device type, application, distribution channel, and region.

By type, the global wearable medical device market has been classified as activity monitors, smart watches, smart clothing, and patches.
Based on device type, the global wearable medical device market has been categorized as diagnostic and monitoring devices and therapeutic devices. The diagnostic and monitoring devices segment has been further sub-segmented into vital sign monitoring devices, glucose monitoring devices, neuromonitoring devices, sleep monitoring devices, and fetal monitoring and obstetric devices. The therapeutic devices segment has been divided into pain management devices, rehabilitation devices, respiratory therapy devices, and insulin pumps.

The various application segments of the global wearable medical device market are sports academics and fitness, remote patient monitoring, and home healthcare.
By distribution channel, the global wearable medical device market has been segmented into hospitals and clinics, diagnostic centers, and ambulatory surgical centers.

Key Players: The key players in the global wearable medical device market are

Apple Inc. (US)
Fitbit Inc. (US)
Honeywell International Inc. (US)
Koninklijke Philips NV (Netherlands)
LG Electronics Inc. (South Korea)
NIKE Inc. (US)
Motorola Solutions Inc. (US)
Qualcomm Inc. (US)
Sony Corporation (Japan)
Omron Corporation (Japan)
Boston Scientific Corporation (US)
and Medtronic PLC (Ireland)

The Objective of the Study

• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global wearable medical device market.
• To provide insights into factors influencing and affecting market growth.
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries.
• To provide strategic profiling of key players in the market and comprehensively analyzing their market shares and core competencies, and drawing a competitive landscape for the market.
• To provide economic factors that influence the global wearable medical device market.
• To provide a detailed analysis of the value chain and supply chain of the global wearable medical device market.

Key Findings

• The global wearable medical device market is expected to reach USD 27,255.6 million by 2023 at a CAGR of 23.0 % from 2018 to 2023.
• On the basis of type, the activity monitors segment accounted for the largest market share at a CAGR of 22.4 % in 2017.
• The market in the Americas is expected to register a CAGR of 22.2% from 2018 to 2023.
• Asia-Pacific is expected to be the fastest-growing market registering a CAGR of 23.7% from 2018 to 2023.

To learn more on the industry, visit @ https://www.aarkstore.com/healthcare/1114325/global-wearable-medical-device-market-forecast-till-2023

Adempas regulatory milestones 2019

Adempas - API Insight, 2019 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Adempas. The report also highlights the patent details of Adempas. 

Adempas API Insight 2019

Methodology

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report.
Patent information around Adempas in United States (US) and Europe (EU) has been highlighted.
API manufacturers for Adempas in United States, Europe, China and India.
The report contains historical and forecasted sales for Adempas till 2021.
Enlists the market competition and emerging therapies in the space where Adempas operates.

Reasons to Buy

Evaluate the marketing status of Adempas to exploit opportunities for generic Adempas development opportunities.
Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Adempas. 
API intelligence over Adempas and gaining primary intelligence over Active Ingredient manufacturers by country.
Make more informed business decisions from insightful and in-depth analysis of the Adempa performance.

For more information or for report request, visit @ https://www.aarkstore.com/pharmaceuticals-healthcare/1050322/adempas-api-insights

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Latest trend in Healthcare Industry with Molecular Modelling

Molecular modeling, as the name itself suggests, is concerned with molecules, their calculations, and predictions with respect to the research field. Molecular modeling can also be stated as an analysis of the ways to mimic the behavior of molecules and molecular systems. Currently, molecular modeling is invariably associated with computer modeling, where computational biology techniques are involved. These molecular modeling techniques are widely used in the chemical and pharmaceutical industry. Molecular modeling plays a crucial role in drug discovery.

molecular modelling market 2023

Molecular modeling has developed as a valuable and essential tool in various healthcare applications such as drug designing, drug development, and drug discovery processes. Molecular modeling describes the generation, manipulation, or representation of three-dimensional structures of molecules and associated physicochemical properties. The growth of the global molecular modeling market is attributed to the increasing investments in research and development by pharmaceutical and biotechnology companies, technological advancements in drug design, and increasing prevalence of various chronic diseases which increases the demand for drug development. However, the high cost of research and development is restraining the growth of the market.

Molecular modeling is a powerful technique in drug designing. The development of new drugs with possible therapeutic applications is one of the most difficult processes in the pharmaceutical industry. In drug designing and discovery, both computational and experimental techniques play important roles and represent complementary approaches. However, molecular modeling is safe and easy to use the tool, which helps in investigating, interpreting, explaining, and identifying molecular properties using three-dimensional structures. During drug designing, molecular modeling tries to predict the structure of the intermolecular complex formed between two or more constituent molecules.

Market Segmentation

The global molecular modeling market is segmented based on the basis of product, application, end-user, and region.

Based on pthe roduct, the market is further segmented into software and services.
Based on application, the market is segmented into drug development, drug discovery, and others.
Based on end-user, the market is segmented into pharmaceutical and biotechnological companies, research centres and academic institutions, and others.

The global molecular modelling market was valued at USD 377 million in 2017 and is expected to register a CAGR of 15.46% from 2018 to 2023.

Key Players

Simulations Plus, Inc., Chemical Computing Group, Certara, L.P, OpenEye Scientific Software, Dassault Systèmes, Cambridge Crystallographic Data Centre, Cresset, Acellera Ltd., Schrödinger, LLC, Optibrium, BioSolve-IT, and others

Study objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global molecular modelling market.

• To provide insights into factors influencing and affecting the market growth.
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries.
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
• To provide economic factors that influence the global molecular modelling market.
• To provide a detailed analysis of the value chain and supply chain of the global molecular modelling market.

Key Findings

• The global molecular modelling market is expected to reach USD 893.1 million by 2023 at a CAGR of 15.46% from 2018 to 2023.
• Based on product, software accounted for the largest market share of 63.1% in the year 2017 and was valued at USD 237.79 million in the same year.
• Based on application, drug discovery accounted for the largest market share of 58.0% in 2017.
• The Americas holds the largest share of the global molecular modelling market which is expected to reach USD 470.6 million by 2023.
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 14.65% from 2018 to 2023.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/983560/global-molecular-modelling-market-research-report-forecast

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

What is Biohacking? – Know the market trends

Also known as Do-It-Yourself (DIY) biology, biohacking is one of the revolutionary change in the field of synthetic biology. It is done by people with an urge of innovation and development of new products that can blend various aspects of synthetic biology and technology. Biohackers are people who perform lab experiments to explore new possibilities of biotechnology, molecular biology, genetic engineering and many other aspects of biology. They perform various experiments on the body, for instance, inserting microchips to control stress level or monitor heart rate.

Biohacking market

Market Segmentation

The global biohacking market is segmented on the basis of type, product, application, and end user.

On the basis of type, market is segmented into outside biohacking, and inside Biohacking, with outside biohacking being the largest market.
On the basis of product, the market is segmented into sensors, smart drugs, strains, and others.
On the basis of application, the market is segmented into synthetic biology, genetic engineering, forensics sciences, diagnosis & treatment, drug testing, and others. Synthetic biology is the largest market.
On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, forensics laboratories, and others.

Key Players

The leading market players in the global Biohacking market include Fitbit, Inc. (U.S.), Apple (U.S.), Synbiota (Canada), THE ODIN (U.S.), HVMN, Inc. (U.S.), Thync Global Inc., U.S.A. (U.S.), Moodmetric (U.S.), and others.

Study objectives of biohacking market:

To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets
To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.
To provide strategic profiling of Key Players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.

Target Audience:

• Medical devices manufacturers
• Medical devices distributors
• Hospitals & Clinics
• Potential investors
• Key executive (CEO and COO) and strategy growth manager

Key Finding

• Outside biohacking segment accounted for the largest market share in 2016 which is valued at USD 3,712.01
• Smart drugs segment accounted for the largest market share in 2016
• Americas region captures the largest market and is expected to reach USD 10573.53 million by 2023
• Globally, Asia Pacific the fastest growing region in the global biohacking market.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/839168/global-biohacking-market-research-report-forecast-to-2023

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Home healthcare market in India

The Home Healthcare Market Research Report offers Market Analysis by Product (Therapeutic products, Other), Service (Skilled Nursing Services, Respiratory Therapy Service, Other), Software (Clinical Management System, Telehealth Solution, Other), Global Forecast Till 2023.

Market Analysis

Home healthcare is an expanding practical choice being favored by patients inferable from increasing healthcare costs and the thriving geriatric populace. Home healthcare services provide one with different services including physical therapy, occupational therapy, speech therapy, and skilled nursing. The digitization of information has made it less complex for the patients to contact doctors and physicians and gain a precise diagnosis from their home. The global home healthcare market is expected to grow at a CAGR of 8.1% during the forecast period 2017 to 2023.

Global Home Healthcare Market 2023

Various technical and scientific advances in healthcare and other diagnosis devices along with several other government initiatives are encouraging the home healthcare system to fuel the market demand in the upcoming years. This type of home healthcare system has made it very easier for the senior or aged and bedridden patients to get in touch with their physicians and recuperate normally.

Market Segmentation

The global home healthcare market is divided on the basis of its product, software, service, and regional demand. Based on its product, the market is segmented into the screening, therapeutic and testing, and monitoring products. On the basis of its software, the global market is bifurcated into agency software, telehealth solution, hospice solutions, and clinical management systems. Based on its services, the market is classified into unskilled care services, skilled nursing services, respiratory therapy services, infusion therapy services, rehabilitation therapy services, and pregnancy care services.

Regional Analysis

The global home healthcare market is divided into four major global regions including Europe, Asia Pacific (APAC), North America, and the Middle East and Africa (MEA).

Major Players

The major players in the home healthcare market include brands like Koninklijke Philips N.V. (The Netherlands), A&D Company (Japan), F. Hoffmann-La Roche AG (Switzerland), Fresenius SE & Co KGaA (Germany), GE Healthcare (U.S.), Abbott (U.S.), McKesson Corporation (U.S.), Becton Dickinson Company (U.S.), B. Braun Melsungen AG (Germany), Omron Corporation (Japan), LG Electronics (South Korea), Medtronic PLC (U.S.), Kinnser Software (U.S.), 3M (U.S.), Apple (U.S.), and others.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/1038995/global-home-healthcare-market-research-report-forecast-till-2023

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Needle free injection demands

The needle free injection system is a novel technique used to introduce medicines to patients without piercing the skin with conventional needles. This technology offers the benefit of reducing patient concern about the use of needles. These injections are very effective for a wide range of drugs and results in less pain and hence are strongly preferred by patients. Additional benefits of these needle free injections include fast results as compared to conventional needles and no issue of needle disposal. This technique could be used to administer vaccines and medications in the pork industry. The rising prevalence of various chronic diseases is propelling the need for needle free injections. Increase in investments in the pharmaceutical sector and convenient use of these medical devices in home care are projected to drive market growth over the forecast period. However, the high cost of these devices, strict regulatory bodies, and stringent regulatory policies are expected to restrain market growth during the forecast period.

Needle Free Injection Market Research Report 2023 

Market Segments

The global needle free injection market has been segmented, by product, technology, usability, type of medication, site of delivery, application, and end user.

Based on product type, the global needle free injection market has been categorized as fillable needle free injectors and prefilled needle free injectors.
On the basis of technology, the global needle free injection market is further sub-segmented into jet-based, spring-based, and laser-powered.
By usability, the global needle free injection market is further sub-segmented into reusable needle free injectors and disposable needle free injectors.

The global needle free injection market was valued at USD 10,377.7 million in 2017 and is expected to register a CAGR of 15.28 % during the forecast period from 2017 to 2023. 

The global needle free injection market by type of medication is further sub-segmented into liquid-based needle free injectors, powder-based needlefree injectors, and projectile/depot-based needle free injectors.

On the basis of site of delivery, the global needle free injection market is further sub-segmented into intradermal injectors, intramuscular injectors, and subcutaneous injectors.
By application, the global needle free injection market is further sub-segmented into vaccination, insulin delivery, and oncology.
On the basis of end user, the market has been classified as hospitals and clinics, ambulatory surgical centers, and home care settings.

Key Players

Some of The Key Players in the global needle free injection market are Antares Pharma Inc., Endo Pharmaceuticals Inc., PharmaJet Inc., Inovio Pharmaceuticals Inc., Medical International Technology Inc., INJEX Pharma GmBH, National Medical Products Inc, European Pharma Group, PenJet Corporation, Valeritas Holdings Inc, Crossject, Mika Medical Co., and DAntonio Consultants International Inc.

Key Findings

• The global needle free injection market is expected to reach USD 25,057.4 million by 2023 at a CAGR of 15.28 % from 2017 to 2023.
• Based on technology, the jet-based needle free injectors segment holds the largest market share and is expected to reach USD 10,391.3 million by 2023 at a CAGR of 15.90% from 2017 to 2023.
• The market in the Americas is expected to account for the largest share of the global needle free injection market and is projected to reach USD 8,750.7 million by 2023.
• The needle free injection market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 15.74 % from 2017 to 2023.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/1039003/global-needle-free-injection-market-research-report-information-forecast-till-2023

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Understanding Circulating Tumor Cell - Cancer Research and Cure

Circulating Tumor Cell Market

Circulating Tumor Cell Market Research Report 2023

Circulating tumor cells (CTCs) are cancer cells that are separated from the solid tumor and enter the bloodstream. Circulating tumor cells can be used as a blood biomarker for the early diagnosis of carcinogenesis and cancer and help to monitor metastatic breast, colorectal, and prostate cancers.

The growth of the circulating tumor cells market can be driven by the growing prevalence of cancer, rising research and development in the biotechnology and pharmaceutical industry, and rising geriatric population. The growing prevalence of cancer is driving the growth of the market, as circulating tumor cells find their applications in the diagnosis of cancer and precision management. For instance, the National Center for Biotechnology Information (NCBI) stated that the projected cases of prostate cancer all over India for the year 2015 were 28,079. Furthermore, the Leukemia & Lymphoma Society estimated that around, 60,300 people are expected to be diagnosed with leukemia in 2018. The significant growth in the population of cancer patients is paving a way for the growth of the circulating tumor cells market.

The global circulating tumor cells market was valued USD 9393.1 million in 2017 and is expected to register a CAGR of 20.32% % over the forecast period.

Similarly, according to the National Health and Medical Research Council, the Australian government spent over USD 174.6 million on cancer research and development. This growing research and development in the field of healthcare are leading to the growth of the circulating tumor cells market.

Market Segmentation

The global circulating tumor cells market is segmented based on application, technology, and end-user.
Based on application, the market is further segmented into clinical, research, and drug development.
Based on technology, the market is segmented into CTC enrichment, CTC detection, and combined enrichment and separation of CTC (CTC analysis).
Based on end-user, the market is segmented into hospitals and clinics, research and academic institutes, and diagnostic centers.

Key Players

Greiner Bio-One International GmbH, Ikonisys Inc., Thermo Fisher Scientific, SRI International, STEMCELL Technologies, Miltenyi Biotec, Menarini Silicon Biosystems, QIAGEN Hannover (QIAGEN), F. Hoffmann-La Roche Ltd, NanoString Technologies, Inc., Fluxion Biosciences, Inc., and GE Healthcare, among others.

Study objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global circulating tumor cells market.
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global circulating tumor cells market
• To provide a detailed analysis of the value chain and supply chain of the global circulating tumor cells market

Target Audience

• Pharmaceutical and Biotechnology Companies
• Medical Devices Companies
• Research and Development (R&D) Institutes
• Market Research and Consulting Service Providers
• Potential Investors

Key Findings

• The global circulating tumor cells market is expected to reach USD 28,399.2million by 2023 at a CAGR of 20.32% from 2018 to 2023.
• On the basis of application, the clinical segment accounted for the major market share of 63% and was valued at USD 5,920.9 million in 2017.
• On the basis of technology, the CTC enrichment accounted for a major market share of 58.5% in 2017.
• The Americas holds the largest share of the global circulating tumor cells market which is expected to reach USD 13,011.5 million by 2023.
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 20.84% from 2018 to 2023.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/980717/global-circulating-tumor-cell-market-research-report-forecast

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

What is Radiopharmaceutical?

Global Radiopharmaceutical Market Analysis and Forecast 2023

Radiopharmaceuticals are those radioisotopes when used for diagnosis or therapy, typically stimulate no physiological response from the patient. They are the unique medicinal formulations containing radioisotopes which can be used diagnosis and treatment of various chronic diseases. Radioisotopes play a very crucial part in the medical diagnostic procedures. In combination with imaging devices which record the gamma rays emitted from inside, healthcare professionals can study the dynamic processes taking place in various parts of the body.

Radiopharmaceuticals market report

The increasing prevalence of chronic diseases which indicates the growing need for early diagnosis and treatment is one of the major factors responsible for the growth of the market. Moreover, rising expenditure in oncology and the growing emphasis on cancer management has also accelerated the market growth owing to the need for new diagnostic and treatment options for common as well as rare cancers.

Both diagnostic & treatment characteristics of radiopharmaceutical driving the market growth. As per the World Nuclear Association, in a quarter of the world population, about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this. Nuclear medicine uses radiation to provide diagnostic information about the functioning of a persons specific organs and used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells.

Increasing Prevalence of Chronic Diseases is also driving the growth of the market. According to the World Cancer Research Fund International, in 2015, cancer was responsible for 8.8 million deaths and is the second leading cause of death across the globe. As per the American Heart Association, in 2017, about 92.1 million Americans were diagnosed with cardiovascular disease. Additionally, as per the National Research University Higher School of Economics, tension-type headaches (about 1,500 million cases), migraine (about 1,000 million), medication overuse headaches (about 60 million), and Alzheimers disease and other dementias (about 46 million cases) are the most common type of neurological disorders in 2015.

Whereas certain factors such as the high cost of radiopharmaceuticals are restraining the growth of the market. As per National Research Universal (NRU), the cost of some nuclear medicine have increased by as much as 1,000 percent recently. Similarly, according to the research, the overall financial cost for the underutilized radiopharmaceutical materials due to canceled and rescheduled procedures for 142 patients was about 39,760 US dollar. The daily financial loss from these cancellations was between USD 560 to USD 1120.

The global radiopharmaceuticals market is expected to reach to the market value of USD 10,473.88 million by 2023 from USD 5,841.22 million in 2016 and have a CAGR of 8.7% during the forecast period, 2017–2023.

On the basis of type, the market for Radiopharmaceutical is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals By type, the market for diagnostic type radiopharmaceuticals accounted for the largest market share in 2017.

On the basis of the type of tests, the market for Radiopharmaceutical is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan, and others. By type of tests, the market for intermediate Radiopharmaceutical accounted for the largest market share in 2017.

The global Radiopharmaceutical, by application, is segmented into oncology, cardiology, neurology, urology, and others. By application, the market for Oncology accounted for the largest market share in 2017.

The global Radiopharmaceutical, by route of administration, is segmented into oral, intravenous and other routes of administration. The intravenous segment holds the largest market share in global Radiopharmaceutical, by route of administration.

On the basis of the route of administration, the global Radiopharmaceutical market is segmented into intravenous, intravitreal, and others. The intravitreal segment dominates the global Radiopharmaceutical market.

The global Radiopharmaceutical, on the basis of end-user, is segmented into hospitals, diagnostic centers, research institutes, and others. Hospitals hold the largest market share in the global Radiopharmaceutical market.

Key Players

The key players for the Radiopharmaceutical market are Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Siemens, Avid Radiopharmaceuticals, IBA Dosimetry and Others.

Study Objectives

• To provide historical and forecast revenue of the market segments and sub-segments with respect to – regional markets and their countries
• To provide insights into factors influencing and affecting the market growth
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global Radiopharmaceutical market

Target Audience

• Pharmaceutical and Medical Device Industries
• Potential Investors
• Medical Research Institutes
• Key Executive (CEO and COO) and Strategy Growth Manager
• Research Companies

Key Findings

• The major market players in the global Radiopharmaceutical market are F Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Siemens, Avid Radiopharmaceuticals, IBA Dosimetry and Others.
• Siemens accounted for more than 13.2% share of the global Radiopharmaceutical Market
• Based on type of tests, Bone Scan segment accounts the largest market share which is expected to reach USD 2,513.68 million by 2023 from USD 1,470.34 million in 2016
• Based on application, the market for oncology is expected to reach USD 4,747.76 million by 2023
• Based on route of administration, intravenous segment was the largest segment in the year 2017 and is expected to reach USD 7,316.86 million by 2023 from USD 3,995.90 million in 2016
• On the basis of region, Asia pacific region is projected to be the fastest growing region, at a CAGR of 9.3% during the forecast period. 

For more information or for report request, visit @https://www.aarkstore.com/healthcare/974583/global-radiopharmaceutical-market-research-report-forecast

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Economic factors that influence the global sterility testing market

Global Sterility Testing Market Research Report and Forecast 2023

Sterility testing is carried out to confirm that products are free from microorganisms. It is imperative for medical devices, vaccines, pharmaceuticals, preparations, tissue materials, and other materials to be tested for sterility. Sterilization can be carried out in various ways including heat, chemicals, irradiation, high pressure, and filtration. Sterilization is similar to disinfection, sanitization, and pasteurization.

The global sterility testing market was valued at USD 540.1 million in 2017 and is expected to register a CAGR of 11.10% during the forecast period from 2018 to 2023. 

In the sterilization process, microorganisms are either killed or are made inactive while biological agents are also eliminated. Most medical and surgical devices used in the pharmaceuticals industry are made of materials that are heat stable and therefore undergo heat, primarily steam, sterilization. However, increasingly, medical devices and instruments are being made of materials that require low-temperature sterilization.

The prevalence of chronic and highly communicable diseases such as AIDS is a major driver for market growth. The other factors responsible for market growth are innovation in drugs and government initiatives.
However, strict regulatory bodies and stringent regulatory policies are expected to restrain market growth during the forecast period.

The global sterility testing market has been segmented by product type, test type, and end user.

The global sterility testing market has been divided, by product type, into instrument, consumable, and services.

Based on the test type, the global sterility testing market has been categorized as membrane filtration, direct transfer sterility testing, and product flush sterility testing.

On the basis of the end user, the market has been classified as hospitals and clinics, pharmaceuticals industry, and academics and research laboratories

Key Players

Some of the Key Players in the global sterility testing market are Merck KGaA (Germany), Pacific BioLabs Inc (US), Belimed Deutschland GmbH (Germany), Boston Scientific Corporation (US), Charles River Laboratories Inc. (US), Sartorius AG (Germany), BioMérieux SA (France), Baxter BioPharma Solutions (US), Astell Scientific (UK), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Becton Dickinson and Company (US), WuXi AppTec (China), Bioquell UK Ltd (UK), and Azbil Telstar SL (Spain). 

Objectives of the Study

• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global sterility testing market
• To provide insights into factors influencing and affecting market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries 
• To provide strategic profiling of Key Players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market 
• To provide economic factors that influence the global sterility testing market
• To provide a detailed analysis of the value chain and supply chain of the global sterility testing market 

Key Findings

• The global sterility testing market is expected to reach USD 942.5 million by 2023 at a CAGR of 11.10% from 2018 to 2023. 
• On the basis of the test type, the membrane filtration segment accounted for the largest market share of 9.8% in 2017 and was valued at USD 350.7 million by 2023.
• The market in the Americas is expected to account for the largest share of the global sterility testing market and is projected to reach USD 520 million by 2023. 
• The market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 7.5% from 2018 to 2023.

Regional Analysis

• Americas: North America, US, Canada, Latin America

• Europe: Germany, France, UK, Italy, Spain, Rest of Europe

• Asia-Pacific: Japan, China, India, Australia, South Korea, Rest of Asia-Pacific

• Middle East & Africa: Middle East, Africa

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com